The Knowledge Hub

Seeley, M.C.  O’Brien, H.  Gallagher, C. Schild, C.  and Lau, D. H.  (2024) Autonomic dysfunction in post-acute sequelae of COVID-19. European Journal of Internal Medicine Vol. 127 Pages 161-163 DOI: 10.1016/j.ejim.2024.06.023

Peebles, K. C., Jacobs, C., Makaroff, L., & Pacey, V. (2024). The use and effectiveness of exercise for managing postural orthostatic tachycardia syndrome in young adults with joint hypermobility and related conditions: A scoping review. Autonomic Neuroscience: Basic and Clinical, 252. DOI:10.1016/j.autneu.2024.103156

Seeley, MC. (2024). Paradigm Shift: The Lived Experience of a Researcher with Postural Orthostatic Tachycardia Syndrome. In: Stranieri, A., Meredith, G., Firmin, S. (eds) Research Partners with Lived Experience. Springer, Singapore. https://doi.org/10.1007/978-981-97-0033-2_1

Seeley, MC, Gallagher, C, Lau, D.H. (2024) Emerging role of autonomic modulation by transcutaneous vagus nerve stimulation: Electrifying hope in POTS? Journal of the American College Cardiology EP.  Feb, 10 (2) 356–358.
https://doi.org/10.1016/j.jacep.2023.11.024

Seeley, M. C. Gallagher, C. Ong, E. Langdon, A. Chieng, J. Bailey, D. Page, A.J. Lim, H. Lau, D H. (2023). High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: Implications for management and health care planning. The American Journal of Medicine, S0002-9343(23)00402-3. Advance online publication. DOI:10.1016/j.amjmed.2023.06.0107/s10286-023-00955-9

Seeley, M. C. Gallagher, C. Ong, E. Langdon, A. Chieng, J. Bailey, Dennis, A. McCaffrey, N. Lau, D H. (2023). Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population. Clinical Autonomic Research  33(4), 469–477. DOI: 10.1007/s10286-023-00955-9 

Seeley MC, Lau DH, Gallagher C.  (2023) Postural Orthostatic Tachycardia Syndrome: Diagnosis and Management Guide for Nurses. Nursing: Research and Reviews;13:41-49
DOI:10.2147/NRR.S394822

Seeley, M.C. Gallagher, C. Colman, F. & Lau, D. H. (2023). Impact of Long-COVID on Australian Sufferers: Implications for Healthcare Planning. Heart, Lung & Circulation, 32(10), e76–e77. DOI:10.1016/j.hlc.2023.09.002

Seeley, M.C., Hooper, M. Tan, J. Wells, R. Gallagher. C. and Lau, D.H. (2023).Plasma exchange improves cognitive function in long-COVID-related postural orthostatic tachycardia syndrome and autoimmune neurological dysfunction. The American Journal of Medicine, DOI: 10.1016/j.amjmed.2023.01.043

Malik, V, Nguyen, M, Seeley, M. et al. (2022) Abnormal cardiac remodeling in postural orthostatic tachycardia syndrome: Further insights into its cardiac origin. Journal American College Cardiology EP. 2022 Aug, 8 (8) 1044–1046.
https://doi.org/10.1016/j.jacep.2022.02.012

Seeley, M. C.  Thynne, T. R.  Braund, W. J.  Worthley, D. L.  Gallagher, C.  Sanders, P.  Lau, D. H.  (2021) Desmopressin as a novel long-term treatment in postural tachycardia syndrome patients with polyuria. The American Journal of Medicine 2021 Vol. 134 Issue 9 Pages e486-e487 DOI: 10.1016/j.amjmed.2021.03.028

Seeley, MC. and Lau, D.H. (2021) Raising the bar in postural orthostatic tachycardia syndrome research: Evidence and challenges. Autonomic Neuroscience: Basic and Clinical, Volume 233, 102790 DOI: 10.1016/j.autneu.2021.102790

Wells, R., Malik, V., Brooks, A. G., Linz, D., Elliott, A. D., Sanders, P., Page, A., Baumert, M., & Lau, D. H. (2020). Cerebral blood flow and cognitive performance in postural tachycardia syndrome: Insights from sustained cognitive stress test. Journal of the American Heart Association, 9(24), 1-10. https://doi.org/10.1161/JAHA.120.017861

Wells, R., Paterson, F., Bacchi, S., Page, A., Baumert, M., & Lau, D. H. (2020). Brain fog in postural tachycardia syndrome: An objective cerebral blood flow and neurocognitive analysis. Journal of Arrhythmia, 36(3), 549-552. https://doi.org/10.1002/joa3.12325

Wells, R., Hissaria, P., Elliott, A. D., Sanders, P., Page, A., Baumert, M., & Lau, D. H. (2020). Plasma Exchange Therapy in Postural Tachycardia Syndrome: A Novel Long-Term Approach? The American Journal of Medicine, 133(4), e157-e159. https://doi.org/10.1016/j.amjmed.2019.10.016

Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018). Efficacy of therapies for postural tachycardia syndrome: A systematic review and meta-analysis. Mayo Clinic Proceedings, 93(8), 1043-1053. https://doi.org/10.1016/j.mayocp.2018.01.025

Wells, R., Spurrier, A. J., Linz, D., Gallagher, C., Mahajan, R., Sanders, P., Page, A., & Lau, D. H. (2017). Postural tachycardia syndrome: current perspectives. Vascular Health and Risk Management, 14, 1-11. https://doi.org/10.2147/VHRM.S127393

Marques, F. Z., Eikelis, N., Bayles, R. G., Lambert, E. A., Straznicky, N. E., Hering, D., Esler, M. D., Head, G. A., Barton, D. A., Schlaich, M. P., & Lambert, G. W. (2017). A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. Molecular Psychiatry, 22(1), 134-141. DOI:10.1038/mp.2016.40

Wells, R., & Tonkin, A. (2016). Clinical approach to autonomic dysfunction [Article]. Internal Medicine Journal, 46(10), 1134-1139. https://doi.org/10.1111/imj.13216

George, S. A., Bivens, T. B., Howden, E. J., Saleem, Y., Galbreath, M. M., Hendrickson, D., Fu, Q., & Levine, B. D. (2016). The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting. Heart Rhythm, 13(4), 943-950. https://doi.org/10.1016/j.hrthm.2015.12.012

Anderson, J. W., Lambert, E. A., Sari, C. I., Dawood, T., Esler, M. D., Vaddadi, G., & Lambert, G. W. (2014). Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol, 5, 230. DOI:10.3389/fphys.2014.00230

Bayles, R., Kn, H., Lambert, E., Baker, E. K., Agrotis, A., Guo, L., Jowett, J. B. M., Esler, M., Lambert, G., & El-Osta, A. (2012). Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome [Article]. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8), 1910-1916. DOI:10.1161/ATVBAHA.111.244343

Baumert, M., Lambert, E., Vaddadi, G., Sari, C. I., Esler, M., Lambert, G., Sanders, P., & Nalivaiko, E. (2011). Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clinical Neurophysiology, 122(2), 405-409. DOI:10.1016/j.clinph.2010.06.017

Lambert, E., Eikelis, N., Esler, M., Dawood, T., Schlaich, M., Bayles, R., Socratous, F., Agrotis, A., Jennings, G., Lambert, G., & Vaddadi, G. (2008). Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circulation. Arrhythmia and electrophysiology, 1(2), 103-109. DOI: 10.1161/CIRCEP.107.750471

Vasavada, A. M., Verma, D., Sheggari, V., Ghetiya, S., Chirumamilla, P. C., Kotak, R. A., Mahapatra, S. S., Patel, T., & Jain, M. (2023). Choices and challenges with drug therapy in postural orthostatic tachycardia syndrome: A systematic review. Cureus, 15(5), e38887. DOI:10.7759/cureus.38887

Seeley, M. C.  Thynne, T. R.  Braund, W. J.  Worthley, D. L.  Gallagher, C.  Sanders, P.  Lau, D. H.  (2021) Desmopressin as a novel long-term treatment in postural tachycardia syndrome patients with polyuria. The American Journal of Medicine 2021 Vol. 134 Issue 9 Pages e486-e487 DOI: 10.1016/j.amjmed.2021.03.028

Taub, P. R., Zadourian, A., Lo, H. C., Ormiston, C. K., Golshan, S., & Hsu, J. C. (2021). Randomized trial of ivabradine in patients with hyperadrenergic postural orthostatic tachycardia syndrome. Journal of the American College of Cardiology, 77(7), 861-871. DOI:10.1016/j.jacc.2020.12.029

Hasan, B., Almasri, J., Marwa, B., Klaas, K. M., & Fischer, P. R. (2020). Treatment of postural orthostatic tachycardia syndrome with medication: A systematic review. J Child Neurol, 883073820948679. DOI:10.1177/0883073820948679

Wang, S., Zou, R., Cai, H., Wang, Y., Ding, Y., Tan, C., Yang, M., Li, F., & Wang, C. (2020). Heart rate and heart rate difference predicted the efficacy of metoprolol on postural tachycardia syndrome in children and Adolescents. Journal of Pediatrics, 224, 110-114. DOI:10.1016/j.jpeds.2020.05.017

Towheed, A., Nesheiwat, Z., Mangi, M. A., Karabin, B., & Grubb, B. P. (2020). Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study. Cardiology in the young, 30(7), 975-979. DOI:10.1017/S1047951120001341

Wells, R., Hissaria, P., Elliott, A. D., Sanders, P., Page, A., Baumert, M., & Lau, D. H. (2020). Plasma exchange therapy in postural tachycardia syndrome: A novel long-term approach? The American Journal of Medicine, 133(4), e157-e159. https://doi.org/10.1016/j.amjmed.2019.10.016

Deng, X., Zhang, Y., Liao, Y., & Du, J. (2019). Efficacy of β-blockers on postural tachycardia syndrome in children and adolescents: A Systematic Review and Meta-Analysis. Frontiers in pediatrics, 7, 460. DOI:10.3389/fped.2019.00460

Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018). Efficacy of therapies for postural tachycardia syndrome: A systematic review and meta-analysis. Mayo Clinic Proceedings, 93(8), 1043-1053. https://doi.org/10.1016/j.mayocp.2018.01.025

Delle Donne, G., Rosés Noguer, F., Till, J., Salukhe, T., Prasad, S., & Daubeney, P. (2018). Ivabradine in postural orthostatic tachycardia syndrome: Preliminary wxperience in children. American Journal of Cardiovascular Drugs, 18(1), 59-63. DOI:10.1007/s40256-017-0248-x

Gee, M. E., Watkins, A. K., Brown, J. N., & Young, E. J. A. (2018). Ivabradine for the treatment of postural orthostatic tachycardia syndrome: A systematic review. American Journal of Cardiovascular Drugs, 18(3), 195-204. DOI:10.1007/s40256-017-0252-1

Ruzieh, M., Sirianni, N., Ammari, Z., Dasa, O., Alhazmi, L., Karabin, B., & Grubb, B. (2017). Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing & Clinical Electrophysiology, 40(11), 1242-1245. DOI:10.1111/pace.13182

Zhao, J., Du, S., Yang, J., Lin, J., Tang, C., Du, J., & Jin, H. (2014). Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children [Article]. American Journal of Cardiology, 114(4), 601-605. DOI:10.1016/j.amjcard.2014.05.039

Liao, Y., Yang, J., Zhang, F., Chen, S., Liu, X., Zhang, Q., Ai, Y., Wang, Y., Tang, C., Du, J., & Jin, H. (2013). Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. American Journal of Cardiology, 112(6), 816-820. DOI:10.1016/j.amjcard.2013.05.008

Arnold, A. C., Okamoto, L. E., Diedrich, A., Paranjape, S. Y., Raj, S. R., Biaggioni, I., & Gamboa, A. (2013). Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. Neurology, 80(21), 1927-1933. DOI:10.1212/WNL.0b013e318293e310

Zhang, F., Li, X., Ochs, T., Chen, L., Liao, Y., Tang, C., Jin, H., & Du, J. (2012). Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. Journal of the American College of Cardiology (JACC), 60(4), 315-320. https://pubmed.ncbi.nlm.nih.gov/22813609/

Coffin, S. T., Black, B. K., Biaggioni, I., Paranjape, S. Y., Orozco, C., Black, P. W., Dupont, W. D., Robertson, D., & Raj, S. R. (2012). Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart rhythm, 9(9), 1484-1490. DOI:10.1016/j.hrthm.2012.05.002

Kanjwal, K., Karabin, B., Sheikh, M., Elmer, L., Kanjwal, Y., Saeed, B., & Grubb, B. P. (2011). Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol, 34(6), 750-755. DOI:10.1111/j.1540-8159.2011.03047.x

McDonald, C., Frith, J., & Newton, J. L. (2011). Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. EP: Europace, 13(3), 427-430. DOI:10.1093/europace/euq390

Jamil-Copley, S., Nagarajan, D. V., & Baig, M. K. (2010). Use of ivabradine in postural orthostatic tachycardia syndrome [Article]. JAFIB: Journal of Atrial Fibrillation, 2(1), 745-746. https://pubmed.ncbi.nlm.nih.gov/28496661/

Lai, C. C., Fischer, P. R., Brands, C. K., Fisher, J. L., Porter, C. B. J., Driscoll, S. W., & Graner, K. K. (2009). Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and β-blockers. PACE – Pacing and Clinical Electrophysiology, 32(2), 234-238. DOI:10.1111/j.1540-8159.2008.02207.x

Raj, S. R., Black, B. K., Biaggioni, I., Paranjape, S. Y., Ramirez, M., Dupont, W. D., & Robertson, D. (2009). Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation, 120(9), 725-734. DOI:10.1161/circulationaha.108.846501

Garland, E. M., Gamboa, A., Nwazue, V. C., Celedonio, J. E., Paranjape, S. Y., Black, B. K., Okamoto, L. E., Shibao, C. A., Biaggioni, I., Robertson, D., Diedrich, A., Dupont, W. D., & Raj, S. R. (2021). Effect of high dietary sodium intake in patients with postural tachycardia syndrome. Journal of the American College of Cardiology, 77(17), 2174–2184. https://pmc.ncbi.nlm.nih.gov/articles/PMC8103825/

Williams EL, Raj SR, Schondorf R, Shen WK, Wieling W, Claydon VE. Salt supplementation in the management of orthostatic intolerance: Vasovagal syncope and postural orthostatic tachycardia syndrome. Auton Neurosci. 2022;237:102906. https://pubmed.ncbi.nlm.nih.gov/34823150/

Bourne, K. M., Sheldon, R. S., Hall, J., Lloyd, M., Kogut, K., Sheikh, N., Jorge, J., Ng, J., Exner, D. V., Tyberg, J. V., & Raj, S. R. (2021). Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome. Journal of the American College of Cardiology, 77(3), 285–296. https://pubmed.ncbi.nlm.nih.gov/33478652/

Bourne, K. M., Karalasingham, K., Siddiqui, T., Patel, A., Exner, D., Sheldon, R., & Raj, S. R. (2024). A community-based trial of commercially available compression tights in patients with postural orthostatic tachycardia syndrome. JACC. Clinical electrophysiology, S2405-500X(24)00860-0. Advance online publication. https://pubmed.ncbi.nlm.nih.gov/39614865/

Svensson, A., Svensson-Raskh, A., Holmström, L., Hallberg, C., Bezuidenhout, L., Moulaee Conradsson, D., Ståhlberg, M., Bruchfeld, J., Fedorowski, A., & Nygren-Bonnier, M. (2024). Individually tailored exercise in patients with postural orthostatic tachycardia syndrome related to post-COVID-19 condition – a feasibility study. Scientific reports, 14(1), 20017. https://pubmed.ncbi.nlm.nih.gov/39198662/. Open Access

Wheatley-Guy, C. M., Shea, M. G., Parks, J. K., Scales, R., Goodman, B. P., Butterfield, R. J., & Johnson, B. D. (2023). Semi-supervised exercise training program more effective for individuals with postural orthostatic tachycardia syndrome in randomized controlled trial. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 33(6), 659–672. https://pubmed.ncbi.nlm.nih.gov/37598401/.

Gibbons, C. H., Silva, G., & Freeman, R. (2021). Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial. Heart rhythm, 18(8), 1361–1368. https://pubmed.ncbi.nlm.nih.gov/33482385/.

Reilly, C. C., Floyd, S. V., Lee, K., Warwick, G., James, S., Gall, N., & Rafferty, G. F. (2020). Breathlessness and dysfunctional breathing in patients with postural orthostatic tachycardia syndrome (POTS): The impact of a physiotherapy intervention. Autonomic neuroscience : basic & clinical, 223, 102601. https://pubmed.ncbi.nlm.nih.gov/31743851/

Fu, Q., & Levine, B. D. (2018). Exercise and non-pharmacological treatment of POTS. Autonomic neuroscience : basic & clinical, 215, 20–27 https://pubmed.ncbi.nlm.nih.gov/30001836/. Open access, review of all non pharmacological treatments.

George, S. A., Bivens, T. B., Howden, E. J., Saleem, Y., Galbreath, M. M., Hendrickson, D., Fu, Q., & Levine, B. D. (2016). The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting. Heart rhythm, 13(4), 943–950. https://pubmed.ncbi.nlm.nih.gov/26690066/.

Shibata, S., Fu, Q., Bivens, T. B., Hastings, J. L., Wang, W., & Levine, B. D. (2012). Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. The Journal of physiology, 590(15), 3495–3505. https://pubmed.ncbi.nlm.nih.gov/22641777/. Open access.

Blitshteyn S  and Fedorowski A (2022) The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: more studies are needed. Nature Cardiovascular Research 2022 Vol. 1 Issue 12 Pages 1119-1120 https://doi.org/10.1038/s44161-022-00180-z

Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, Numan M, Peltier A, Snapper H, Vernino S (2021) Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res 31:365-368  https://doi.org/10.1007/s10286-021-00798-2

Seeley M-C, Gallagher C, Colman F, Lau DH (2023) Impact of long-COVID on Australian sufferers: Implications for healthcare planning. Heart, Lung and Circulation https://doi.org/10.1016/j.hlc.2023.09.002

Seeley M-C, Gallagher C, Ong E, Langdon A, Chieng J, Bailey D, Page A, Lim HS, Lau DH (2023) High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: Implications for management and health care planning. The American Journal of Medicine https://doi.org/10.1016/j.amjmed.2023.06.010

Seeley M-C, Hooper M, Tan J, Wells R, Gallagher C, Lau DH (2023) Plasma exchange improves cognitive function in long-COVID-related postural orthostatic tachycardia syndrome and autoimmune neurological dysfunction. The American Journal of Medicine https://doi.org/10.1016/j.amjmed.2023.01.043

Hira R, Baker JR, Siddiqui T, Ranada SI, Soroush A, Karalasingham K, Ahmad H, Mavai V, Ayala Valani LM, Ambreen S, Bourne KM, Lloyd MG, Morillo CA, Sheldon RS, Raj SR (2023) Objective Hemodynamic Cardiovascular Autonomic Abnormalities in Post-Acute Sequelae of COVID-19. Can J Cardiol 39:767-775 https://doi.org/10.1016/j.cjca.2022.12.002

Hira R, Karalasingham K, Baker J.R and Raj S, (2023) Autonomic Manifestations of Long-COVID Syndrome. Current Neurology and Neuroscience Reports https://doi.org/10.1007/s11910-023-01320-z

Kwan AC, Ebinger JE, Wei J, Le CN, Oft JR, Zabner R, Teodorescu D, Botting PG, Navarrette J, Ouyang D, Driver M, Claggett B, Weber BN, Chen P-S, Cheng S (2022) Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 infection. Nat. Cardiovasc. Res. 1:1187-1194 https://doi.org/10.1038/s44161-022-00177-8

Angeles MR, Dinh TTN, Zhao T, de Graaff B, Hensher M (2024) The economic burden of long COVID in Australia: more noise than signal? Med J Aust 221 Suppl 9:S31-s39 https://doi.org/10.5694/mja2.52468

Blitshteyn S, Whiteson JH, Abramoff B, Azola A, Bartels MN, Bhavaraju-Sanka R, Chung T, Fleming TK, Henning E, Miglis MG, Sampsel S, Silver JK, Tosto J, Verduzco-Gutierrez M, Putrino D (2022) Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). Pm r 14:1270-1291 https://doi.org/10.1002/pmrj.12894

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, Redfield S, Austin JP, Akrami A (2020) Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. medRxiv:2020.2012.2024.20248802 https://doi.org/10.1038/s41579-022-00846-2

Fedorowski A and Sutton R (2023) Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol 20:281-282 https://www.ncbi.nlm.nih.gov/pubmed/36732397

Lau, DH. Gallagher, C. & Seeley, MC. (2022, November 26). Postural orthostatic tachycardia syndrome: Therapy update. AusDoc.com.au. LINK

Raj, S. R., Guzman, J. C., Harvey, P., Richer, L., Schondorf, R., Seifer, C., et.al. (2020). Canadian Cardiovascular Society Position Statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol, 36(3), 357-372. DOI:10.1016/j.cjca.2019.12.024

Raj SR, Fedorowski A, Sheldon RS. (2022) Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne 2022;194(10):E378-E385. DOI: 10.1503/cmaj.211373

Blitshteyn, S., Whiteson, J. H., Abramoff, B., Azola, A., Bartels, M. N., Bhavaraju-Sanka, R., et.al. (2022). Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R, 14(10), 1270-1291. DOI:10.1002/pmrj.12894

Vernino, S., Bourne, K. M., Stiles, L. E., Grubb, B. P., Fedorowski, et.al. (2021). Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting – Part 1. Auton Neurosci, 235, 102828. DOI:10.1016/j.autneu.2021.102828

Sheldon, R. S., Grubb, B. P., 2nd, Olshansky, B., Shen, W.-K., Calkins, et.al. (2015). 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart rhythm, 12(6), e41-e63. DOI:10.1016/j.hrthm.2015.03.029 

Seeley, M.C, Gallagher, C. & Lau, D. H (2023). Request for Adoption of a Unique International Classification of Disease Code for Postural Orthostatic Tachycardia Syndrome: Request for Modification to ICD-10-AM/CHI/ACS Classification 10: 13th Edition. Submission to IHACPA LINK HERE

Seeley MC, & Gallagher C. (2022). A Submission to the Inquiry into Long-COVID and Repeated COVID Infections: Postural Orthostatic Tachycardia Syndrome and its Association with Long-COVID. LINK HERE

Seeley MC, & Gallagher C. (2024). A Submission to the Therapeutic Goods Administration: Nomination for the Repurposing of Midodrine for the Indication of treating Postural Orthostatic Tachycardia Syndrome (POTS). LINK HERE

Seeley, MC. Gallagher, C. Wilson, G. Lau, DH. (2023) Experiences of Women with Postural Orthostatic Tachycardia Syndrome in Australia. Submission to the National Women’s Health Advisory Council. LINK HERE